7137 Final analysis of a large open-label, noncomparative, phase 3 study of sorafenib in European patients with advanced RCC (EU-ARCCS)
Work
Year: 2009
Type: article
Cites:
Cited by: 10
Related to: 10
FWCI: 2.283
Citation percentile (by year/subfield): 68.75
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Partnerships for the goals
Open Access status: closed